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Summary Prostatic intraepithelial neoplasia (PIN) has been considered as a precursor of prostatic cancer. Few reports have dealt with the
long-term follow-up of PIN lesions, and there is still a lack of proof that PIN is a true premalignant lesion. The objective of this study was to
evaluate PIN in the transition/central zone as a marker for subsequent development of prostatic cancer. The PIN status of tissue specimens
from 789 men without prostate cancer was determined in 508 transurethral resections and 281 transvesical prostatic enucleations. All slides
were reviewed blind and independently by two pathologists. The patients were followed for an average of 11 years, and the incidence of
subsequent cancer and cause-specific survival were analysed. Thirty-six cases of clinical prostatic cancer occurred among the cohort of 789
men through follow-up. No association between the presence of PIN in the transition/central zone and subsequent cancer development was
found. There was also no difference in survival related to PIN status among the subsequent cancer patients.
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Prostatic intraepithelial neoplasia (PIN). as defined bv Bostwick
and Brawer (1987) is regarded as the most likely precursor of
prostate cancer (Bostwick and Sn'gley. 1990: Bostwick. 1995).
Prostate cancer is the most common male malignancy in most
Western countries. and it is important to identify patients who will
benefit from early curative treatment, particularly with the intro-
duction of organized screening for prostate cancer in some coun-
tries. Intemational consensus conferences (Montironi et al. 1996)
have concurred with this opinion of PIN as a true premalignant
lesion. In particular. high-grade PIN occurs with great frequency
and to a large extent in the prostates of men with cancer of the
prostate (Brawer. 1992a). Convincing evidence of progression
from PIN to cancer. similar to that found for cervical intraepithe-
lial neoplasia (CIN). is. however. lacking. Until now. few reports
have dealt with the long-term follow-up ofPIN lesions.
The main aim of this project was to analyse the risk of subse-
quent prostate cancer in men with different PIN grades in the
transition/central zone ofthe gland.
PATIENTS AND METHODS
All patients were seen as in- or outpatients at two main urological
hospital departments in Oslo during the period 1974-75. A tissue
specimen from each patient was investigated at the Department of
Pathology, Ulleval Hospital. The specimens were re-examined and
reclassified by two pathologists (FS and AB) in 1995. in a blind
fashion. independent of the first investigation. by applying the
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diagnostic criteria for PLN of Bostwick and Brawer (1987). The
presence of PIN [0 (no PIN). grade 1. 2 and 3] or atypical adeno-
matous hyperplasia. the WHO grade and the extent of cancer
(percentage area) were recorded. In cases of discrepancy. a
reassessment was always carried out. Furthermore. the diagnosis
of atypical adenomatous hyperplasia was strictly based on the
cnteria ofa consensus statement (Bostwick et al. 1994).
The material is described in detail in a separate publication
(Skj0rten et al. 1997). and in this paper w-e will only refer to some
basic characteristics. A total of 1230 specimens were originally
collected. None of the total prostatectomies received dunrng the
period 1974 to 1975 (n = 6) was studied further. Nine cases could
not be traced because of insufficient identification. and 19 cases
were excluded because of missing or unsatisfactory histological
material. Sixty-one patients had two or more specimens taken in
the same year. In these cases. only the first specimen was included
in the current study. A total of 1135 histological specimens were
therefore left for examination. Three hundred and twenty-seven
patients were excluded because ofprevious or coexisting cancer as
well as 19 core needle biopsies (assumed to be peripheral zone
tissue). leaving histological specimens from 789 patients to be
examined. Of these. 508 were transurethral resections (TUR-P)
and 281 transvesical prostatic enucleations (TPE). Average age at
diagnosis of these patients wAas 70 years. The patients were
followed up either to 1995 (maximum 20 years) or to death.
comprising 8260 person-years atnrsk. All subsequent cancer cases
were recorded by the Cancer Registry of Norway. and no patients
were lost to follow-up. The follow-up status (dead/alive) and the
cause ofdeath were given as ofJuly 1995 for all patients involved
(in collaboration with Statistics Norway). The Cancer Registry
had information on treatment given during the follow-up period
for registered cancer patients only.
Cancer reporting in Norwav has been compulsory by law since
1952. and the completeness of prostate cancer reporting in the
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Table 1 Exdusons in the material, and distributon of PIN groups among
patients left for analysis. who developed prostate cancer or not
Exclusios Left for analys
Previous Coexisting Core needle Later No
canoer cancer bios cancer cner
Total (1135) 58 269 19 36 (100) 753 (100)
PIN not present 10 (27.8) 275 (36.5)
PIN 1 5 (13.9) 77 (10.2)
PIN 2 14 (38.9) 272 (36.2)
PIN 3 7 (19.4) 129 (17.1)
Numbers in parentheses are percentages.
Table 2 The age-adjusted risk (relative risk) of acquiring prostate cancer
among 789 men who had a histological examination of the prostate in
1974-75, by PIN grading and atypical adenomatous hyperplasia (AAH) (both
classified in 1995, from the orginal specimens)
Variablsw Number Reative ConhFdence P-values
risk interais (95%)
PIN 0 285 1
PIN 1 82 0.86 0.31-2.44 0.82
PIN 2 286 0.81 0.39-1.72 0.58
PIN 3 136 0.79 0.31-1.99 0.62
AAH 0 669 1
AAH 1 120 1.44 0.62-3.35 0.39
Age 1.06 1.01-1.10 0.02
aPIN 0, no PIN lesions; AAH 0, no AAH; AAH 1, AAH present.
Cancer Registry has been found to be higher than 99%c (Harvei et
al. 1996). An essential element in patient identification and record
linkage is the unique 11ligit personal identification (i.d.) number
allocated to each individual born orpermanently living in Norway.
A more extensive description ofthe Cancer Registry is given else-
where (Pedersen and Magnus. 1959).
The following variables from the database of the Cancer
Registry were included: i.d. number, names (for identification of
hospital patients). date of birth. place of residence. date of diag-
nosis. metastasis (±). cancer diagnosis. histology and histological
grade. date and cause of death. Identification of individuals and
linkage of the pathology files were carried out in the Cancer
Registry. All but three ofthe prostate cancercases were verified by
histology or cytology. The TNM stage classification system was
not in widespread use in Norway in 1975 and therefore could not
be properly analysed. The patients examined in 1974-75 had not
been subject to repeated biopsies or controls, unless deemed
necessary by clinical symptoms.
Statistical analysis
The risk of acquiring prostate cancer in the follow-up period
according to PIN grade. adjusted for age and atypical adenomatous
hyperplasia was analysed using Cox's regression model (Cox.
1972) with multiplicative risk (EGRET, Statistical Package.
Statistical and Epidemiology Research. Seattle. WA. USA).
Survival analysis was carried out using the same model. The plots
were, for practical reasons. created by SPSS for Windows (Base
System User's Guide Release 6.0. 1993) and drawn according to
the Kaplan-Meier principle. Differences between the curves were
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Figure 2 Survival of prostate cancer as a function of PIN grade. PIN 0,.
PIN 1, -; PIN 2,--; PIN 3,
analysed using the log-rank test for equality of survival distribu-
tions forPIN. comparing all factor levels in a single test. Statistical
significance was accepted for P < 0.05.
RESULTS
Average follow-up time was 11 years (range 1 month-20 years)
with no difference among the various PIN groups. Thirty-six cases
ofprostate cancer were diagnosed in the follow-up period. Table 1
illustrates the distribution of the total number of patients, with
subsequent cancer or not, among the different PIN groups. The
stage distribution among the 36 prostate cancer patients was. as
expected based on the national patterns (not shown). The relative
risk of subsequent prostate cancer is shown in Table 2. There was
no significant difference in the distribution of subsequent cancer
occurrence of the various PIN groups. adjusted for age and co-
existing atypical adenomatous hyperplasia. A non-significant rela-
tive risk of 1.4 was found forthe riskofsubsequent prostate cancer
among patients with atypical adenomatous hyperplasia. Separate
analyses for TUTR-P and TPE specimens did not provide any addi-
tional information on relative risk (data not shown). The influence
of age on cancer occurrence was observed with a significant rela-
tive risk of 1.06. Figure 1 presents the cumulative incidence of
prostate cancer up to 20 years after first examination; no difference
is seen among the PIN groups (P = 0.99). Figure 2 presents cause-
specific survival analysis by PIN status. indicating no significant
difference (P = 0.70) in the risk ofdying from subsequent prostate
cancer according to PIN status.
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DISCUSSION
A strong association between high-grade PIN and cancer of the
prostate seems to be uniformly supported, and there is also a broad
consensus in regarding PIN as a premalignant lesion (Brawer.
1992a and b; Aboseifet al, 1995; Bostwick, 1995; Montironi et al,
1996). Results of morphometric as well as genetic and molecular
studies also favour the hypothesis that high-grade PIN is a
precursor ofprostatic cancer (Bostwick et al, 1996; Haggman et al.
1997). To consider high-grade PIN as a predictor of subsequent
cancer has important clinical implications. After having identified
high-grade PIN alone in biopsies, repeat biopsies and a close,
long-term surveillance, includingtransrectal ultrasonography and
serum PSA measurements, are clearly needed. There are, however.
objections to the establishment of PIN as a precursor lesion for
prostate cancer (Stone, 1996), asserting that PIN and prostate
cancer could co-occur by chance or that some other factor causes
both. The prevailing concept of PIN being a precursor of cancer is
partly based on the findings of subsequent cancer after the diag-
nosis ofhigh-grade PIN. Hitherto. most of these follow-up studies
have lasted less than 2 years (Aboseif et al, 1995; Davidson et al.
1995; Weinstein and Epstein, 1993), indicating that malignancy
might have been coexistent. A bias, through overdiagnosis of
latent cancer when performing multiple repeat biopsies during
follow-up, could easily occur. Bemer et al (1993) reported that 23
of37 patients with high-grade PIN did not develop cancer during 8
years offollow-up, in agreement with the current report. However,
the mean time from high-grade PIN diagnosis to subsequent
cancer in 14 patients was only 3 months (range 1 month-I year),
most probably indicating that the cancers did coexist. The study of
Bemer et al (1993) was also based solely on tissue from the transi-
tion zone. Garnett and Oyasu (1989) revealed no evidence for
increased risk of subsequent cancer for 'atypical prostate hyper-
plasia' (a lesion that today is assumed to be PIN) over more than
10 years of follow-up.
No definite proof of the progression from dysplasia to invasive
cancer has as yet been given, as it is almost impossible to repeat
biopsy sampling of a particular lesion (Brawer, 1992b). Pending
further advances in this line of research. the term 'putative
precursor' seems, so far, to be the most often used in the literature.
The present report is based on material obtained by TUR-P and
TPE, which is derived from the transition zone and partly from the
central zone. Most prostate cancers have been considered to origi-
nate in the peripheral zone, and previous reports have indicated
that transition zone cancers are mostly small, well differentiated
and frequently incidental findings, in contrast to the less well-
differentiated peripheral zone tumours (McNeal et al, 1988;
Babaian et al, 1991). It has also been suggested that there may be a
precursor other than high-grade PIN for well-differentiated adeno-
carcinoma (Montironi et al, 1996).
McNeal et al (1988) examined 104 total prostatectomy speci-
mens from cancer and found that 24% of the cancers had their
origin in the transition zone, 8% in the central zone and 15% with
unknown origin were found invading the transition zone.
Altogether. 47% of the cancers were accessible to TUR-P. Babaian
et al (1991) identified incidental prostate cancer in cystoprostatec-
tomy specimens that had been resected for bladder cancer. They
found 33% of the tumours to be accessible to TUR-P. They also
found that the cancer was multizonal and occurred simultaneously
in the transition zone and in the peripheral zone in two-thirds of the
cases. In our material (transition/central zone), cancer was found in
25% of the specimens, 44% were large cancers (>50% of area
involved) and 36% were of low differentiation (WHO grade 3).
Few publications state that PIN exists only in the peripheral
zone (De la Torre et al, 1993). Babaian et al, (1991) found that
70% ofpatients withtransition-zone cancer stage A (14 of 20) had
PIN 3 lesions. Epstein et al (1990), in a small study of selected
TUR-P material from stage A incidental carcinomas, found 15.6%
with severe dysplasia (PIN grade 3). Furthennore, in mapping
studies oftotal prostatectomy specimens, Qian et al (1997) noticed
that PIN was multicentric and multizonal and involved the
transition zone in 36% of the cases, although it occurred most
frequently in the peripheral zone. They suggested that the extent
and zonal distribution of high-grade PIN and cancer are strongly
associated. In the current study, the percentage of PIN grade 3 in
the TUJR-P material with small cancers (<25% of section area
involved) was 32% (described in Skj0rten et al, 1997). In addition,
PIN occurrence increases with age. Sakr et al (1994) found that
high-grade PIN (grade 2 and 3) was encountered in up to 63% of
men in the seventh decade. Qian and Bostwick (1995) observed
that the extent of PIN correlated with age. Our patients were
approximately 5 or more years older than the patients studied by
McNeal et al (1988) and Babaian et al (1991). Consequently, our
material would be expected to show either equal or higher
frequency of PIN and cancer in the transition zone than the publi-
cations cited.
Bias may occur in the selection of patients. in the histological
classification of PIN. atypical adenomatous hyperplasia and
prostate cancer, in sampling ofbiopsy specimens or in the registra-
tion of subsequent prostate cancer. We will briefly discuss these
possibilities.
The degree of interobserver agreement. as calculated using
weighted kappa statistics (Skj0rten et al, 1997). was high for PIN
(0.66) and very high (0.86) for the WHO grade, indicating a high
degree of reliability. The kappa coefficient compared favourably
with reported studies on the diagnosis ofPIN and cancer (Allam et
al, 1995; Epstein et al, 1995).
There has never been any organized screening for prostate
cancer in Norway, and PSA and transrectal ultrasonography had
not been introduced in 1975. The patients included are representa-
tive of a male urological population from a medium-sized city.
Twenty years ago, TUR-P was the operation of choice for both
cancer and benign prostatic hyperplasia, whereas TPE was mostly
performed on patients with enlarged prostate who were not
suspected of having malignancy. Besides this, no specific treat-
ment was given for hyperplasia of the prostate, although repeated
resections might have been performed at recurrences. We have
information on treatment for cancer patients only. No patients
were lost to follow-up. The completeness of prostate cancer
reporting to the Cancer Registry has previously been demonstrated
to be higher than 99% (Harvei et al, 1996).
There have only been minorchanges in the processing ofprostatic
specimens since 1974-75, and the average number of blocks has
increased from 3-5 (range 1-12) in our study to 5-6, which is
currently recommended. However, the probability of overlooking
prostate canceris5-10% when only one blockisprocessed(Garborg
andEide, 1985), andthe chance ofunderdiagnosing PIN in thisstudy
should be low. Consequently, we also believe that the problem of
missing prostate canceras aresult ofsampling bias is limited.
One might postulate that therapeutic resection ofprostate tissue
in 1974-75 could result in lower cancer frequency because PIN
lesions and potential cancer tissue were resected. As several
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authors have demonstrated both multicentricity and multizonality
of PIN lesions and cancer in the prostate (McNeal et al. 1988:
Babaian et al, 1991: Qian and Bostwick, 1995). a subsequent
cancer could originate in coexisting PIN lesions that had not been
resected. However, it has not been possible to estimate the total
extent of PIN that was resected by TUR-P or TVE. Examining
cystoprostatectomy specimens after surgery for bladder cancer.
Babaian et al (1991) estimated that approximately 30% of stage A
cancers could theoretically be removed by TUR-P. Thus. if high-
grade PIN lesions in the transition and central zone are to be
considered precursors to cancer, the putative relative cancerrisk of
high-grade PIN should have been preserved, despite the removal
of30% ofthe specimen. When applying national age-specific inci-
dence rates for prostate cancer on the population-at-risk in this
study, the expected number of cases of prostate cancer in this
group was 44 cases vs 36 observed - a reasonable similarity
(P > 0.05). It does not appear. therefore, as if the resection of PIN
lesions influences the successive cancer rate.
Evidence of unusual morphological or biological features or a
substantially different natural history of transition/central zone
PINs or cancers is inconclusive (Montironi et al. 1996). If PIN
lesions in the transition/central zone behave differently compared
with PIN in the peripheral zone, this could explain the results
obtained in this study.
The mean age ofpatients with PIN but no cancer was 69 years.
and there was no difference in age among the PIN groups
(Skj0rten et al. 1997). If the average follow-up period of 11 years
in this study is considered to be too short, the use of high-grade
PIN as a predictor of cancer would be of no practical interest
because median age at diagnosis for prostate cancer patients in
Norway is 75 years.
The lack of an observed statistically significant association
between atypical adenomatous hyperplasia and the risk of subse-
quent cancer is in agreement with the weak and inconclusive
evidence ofatypical adenomatous hyperplasia being a precursor of
cancer (Montironi et al. 1996)
CONCLUSION
No increased risk for subsequent cancer of the prostate was found
in a follow-up of 789 men for an average of 11 years after diag-
nosis of PIN lesions in transurethral and transvesical prostate
resections. This could be explained if PIN lesions were biologi-
cally different in the transition and central zone compared with the
peripheral zone. Likewise, no difference was found among PIN
groups in the survival rate for prostate cancer, but this should be
confmed in a larger study.
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